Phathom Pharmaceuticals Inc.
PHAT | NASDAQ
$7.57
+$0.12 (+1.61%)
Sep 22, 2026, 11:26 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 129.97M | 297.26M | 381.39M | 155.39M | 183.26M | 287.5M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 2.86M | n/a | 505K | n/a | n/a |
Other Long-Term Assets | 26.51M | 13.23M | 12.79M | 299K | 341K | 384K |
Receivables | 78.13M | 38.8M | 1.64M | n/a | n/a | 82K |
Inventory | 5.52M | 3.21M | 1.21M | n/a | n/a | -82K |
Other Current Assets | 15.35M | 20.87M | 13.19M | 5.13M | 3.27M | 3.87M |
Total Current Assets | 228.97M | 360.13M | 397.43M | 160.51M | 186.53M | 291.37M |
Property-Plant & Equipment | 3.67M | 2.09M | 3.62M | 3.49M | 2.56M | 3.36M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 30.18M | 18.18M | 16.41M | 4.3M | 2.91M | 3.74M |
Total Assets | 259.15M | 378.32M | 413.84M | 164.81M | 189.43M | 295.11M |
Account Payables | 4.98M | 10.51M | 12.6M | 10M | 5.15M | 16.78M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 19.78M | n/a | n/a | n/a | 7.35M |
Other Current Liabilities | 49.59M | 54.94M | 20.43M | 8.45M | 6.34M | n/a |
Total Current Liabilities | 132.04M | 85.73M | 38.78M | 26.24M | 18.92M | 55.52M |
Long-Term Debt | 209.09M | 534.67M | 137.84M | 95.26M | 89.67M | 39.63M |
Other Long-Term Liabilities | 354.12M | 11.5M | 309.52M | 117.03M | 7.5M | 4.13M |
Total Long-Term Liabilities | 565.27M | 546.17M | 447.82M | 213.39M | 98.35M | 45.32M |
Total Liabilities | 697.32M | 631.9M | 486.6M | 239.62M | 117.28M | 100.84M |
Total Debt | 211.8M | 554.95M | 139.03M | 97.07M | 91.34M | 49.02M |
Book Value | -438.17M | -253.58M | -72.76M | -74.81M | 72.16M | 194.27M |
Book Value Per Share | -6.01 | -4.01 | -1.42 | -1.91 | 1.95 | 5.85 |
Common Stock | 6K | 6K | 5K | 3K | 3K | 3K |
Retained Earnings | -1.48B | -1.26B | -928.69M | -727.09M | -529.37M | -385.49M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -438.17M | -253.58M | -72.76M | -74.81M | 72.16M | 194.27M |
Total Investments | n/a | 2.86M | n/a | 505K | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PHAT